ICICI Prudential Mutual Fund Shares Decline by Nearly 4% Amid Mixed Q4 Performance and MTM Impact
Back to News
Market4h agoNegativeMedium ImpactShort Term

ICICI Prudential Mutual Fund Shares Decline by Nearly 4% Amid Mixed Q4 Performance and MTM Impact

Detailed Analysis

ICICI Prudential AMC Stock Declines Amid Q4 FY26 Results, Brokerages Maintain Bullish Views

On Wednesday, April 15, ICICI Prudential Asset Management Company Ltd stock traded lower throughout the session, with the shares ultimately settling at Rs 3,221, a 4 percent decline for the day. Despite the short-term setback, the stock has demonstrated resilience, gaining 24.5 percent since its listing in December 2025, with a market capitalisation of Rs 1.59 lakh crore.

The decline in stock value comes on the heels of the company's Q4 FY26 results, which revealed a sequential drop in profit due to mark-to-market (MTM) losses. However, the underlying operating performance remained steady. ICICI Prudential AMC reported a profit of Rs 763 crore for the quarter ended March 31, 2026, a 10 percent year-on-year increase but a 17 percent quarter-on-quarter decline amid market volatility.

The company's revenue from operations rose to Rs 1,517 crore, while operating profit increased 30 percent to Rs 1,128 crore. Brokerages attributed the weakness in the results to MTM losses, while the core performance remained intact.

| Brokerage | Rating | Target Price (per share) | Key Observations | | --- | --- | --- | --- | | CLSA | Outperform | Rs 3,730 | Steady industry conditions, strong SIP and lump-sum flows, and a 40 basis points market share gain in active equity assets under management. | | Citi | Buy | Rs 3,900 | Core profit before tax was in line with estimates, rising 2 percent sequentially. However, it highlighted sluggish average AUM growth due to weak equity sentiment and an unfavourable mix shift that weighed on yields and profitability. | | HSBC | Buy | Rs 3,800 | Earnings beat consensus estimates on higher treasury gains and cost discipline. It expects market share gains, yield levers and operating leverage to support earnings growth. | | UBS | Buy | Rs 3,900 | Core performance was strong despite MTM-related impact on headline earnings. It highlighted continued franchise momentum driven by equity and hybrid fund outperformance, improving margins, and manageable near-term yield headwinds. |

Brokerages such as CLSA, Citi, HSBC, and UBS maintained their bullish views on the long-term outlook for ICICI Prudential AMC, despite the short-term decline in stock value. These brokerages cited factors such as steady industry conditions, strong SIP and lump-sum flows, and market share gains as positives for the company.

Operationally, the company saw a mixed trend in assets under management during the quarter. Total mutual fund QAAUM stood at Rs 11,048 billion with a 13.5 percent market share, while active MF QAAUM was Rs 9,206 billion with a 13.7 percent share. Equity schemes accounted for Rs 6,204 billion, with a 14.2 percent market share.

Investor Takeaway

Investors should be cautious of the short-term market volatility and focus on the long-term outlook of the company.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
help@iposcanner.ai.

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.